Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2024

Oct 1, 2024

32093_dirs_2024-09-30_a60689ab-beb5-4cf0-8697-0d541dc1f326.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2024-09-24

Reporting Person: Levinson Mitchell E. (Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-09-24 Common Stock X 3000 $11 Acquired 93880 Direct
2024-09-24 Common Stock X 1240 $11 Acquired 21240 Indirect
2024-09-24 Common Stock X 322 $11 Acquired 8321 Indirect
2024-09-24 Common Stock X 322 $11 Acquired 8421 Indirect
2024-09-24 Common Stock X 322 $11 Acquired 8521 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-09-24 Warrant (right to buy) $11 X 1500 Disposed 2029-07-03 Common Stock (1500) Direct
2024-09-24 Warrant (right to buy) $11 X 1500 Disposed 2029-07-03 Common Stock (1500) Direct
2024-09-24 Warrant (right to buy) $11 X 620 Disposed 2029-07-03 Common Stock (620) Indirect
2024-09-24 Warrant (right to buy) $11 X 620 Disposed 2029-07-03 Common Stock (620) Indirect
2024-09-24 Warrant (right to buy) $11 X 161 Disposed 2029-07-03 Common Stock (161) Indirect
2024-09-24 Warrant (right to buy) $11 X 161 Disposed 2029-07-03 Common Stock (161) Indirect
2024-09-24 Warrant (right to buy) $11 X 161 Disposed 2029-07-03 Common Stock (161) Indirect
2024-09-24 Warrant (right to buy) $11 X 161 Disposed 2029-07-03 Common Stock (161) Indirect
2024-09-24 Warrant (right to buy) $11 X 161 Disposed 2029-07-03 Common Stock (161) Indirect
2024-09-24 Warrant (right to buy) $11 X 161 Disposed 2029-07-03 Common Stock (161) Indirect

Footnotes

F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.

F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.